Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination
Neuromyotonia is a rare peripheral nerve hyperexcitability syndrome often associated with antibodies directed against contactin-associated protein-like 2 and leucine-rich, glioma inactivated 1. The quadrivalent human papilloma virus vaccine Gardasil<sup>®</sup>, first approved in 2006, i...
Main Authors: | Maryam Hatami, Moritz Förster, Vivien Weyers, Saskia Räuber, Sven G. Meuth, David Kremer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1132 |
Similar Items
-
Axonal Neuropathy with Neuromyotonia
by: J Gordon Millichap, et al.
Published: (2014-02-01) -
Bilateral oculomotor ocular neuromyotonia: a case report
by: Tanyatuth Padungkiatsagul, et al.
Published: (2018-09-01) -
Focal neuromyotonia as a presenting feature of lumbosacral radiculopathy
by: Tushar Premraj Raut, et al.
Published: (2013-01-01) -
PHARMACOECONOMIC EFFICIENCY OF QUADRIVALENT VACCINE TO PREVENT HPV-ASSOCIATED DISEASES
by: I. A. DYAKOV
Published: (2016-12-01) -
Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
by: Juan J. Hernandez-Aguado, et al.
Published: (2022-03-01)